CorMedix CRMD
NASDAQ CRMD
$5.37 -0.10 (-1.83%)
At close: Nov 10, 2026 · 4:00 PM EST

CorMedix (CRMD) Convertible Debt (2012 - 2019)

Updated

CorMedix (CRMD) posted Convertible Debt of $6.73 million for Q2 2019, up 4.8% from the prior quarter.

Analysis

CorMedix (CRMD) Convertible Debt (2012 - 2019) Analysis & Trends

At the end of FY2018, CorMedix's Convertible Debt came in at $6.13 million.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,264.65 Bn 1,238.27 Bn 20.46 Bn
2 Johnson & Johnson 677.74 Bn 597.60 Bn 17.30 Bn
3 AbbVie 517.10 Bn 485.11 Bn 13.12 Bn
4 Merck 362.23 Bn 325.17 Bn 13.19 Bn
5 Novartis Ag 315.90 Bn 276.16 Bn 11.24 Bn
6 Astrazeneca 289.40 Bn 266.24 Bn 12.86 Bn
7 Amgen 249.90 Bn 201.56 Bn 7.58 Bn
8 Gilead Sciences 209.15 Bn 184.26 Bn 6.73 Bn
9 Pfizer 165.88 Bn 113.23 Bn 12.56 Bn
10 CorMedix 438.89 Mn -201.00 Mn 77.13 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2019 6.73 Mn
Mar 31, 2019 6.43 Mn
Dec 31, 2018 6.13 Mn
Mar 31, 2013 207,467.00
Dec 31, 2012 16,061.00
Sep 30, 2012 42,540.00
API Access

CorMedix Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=CRMD&period=max&api_key=YOUR_API_KEY